Variant report
Variant | nsv584324 |
---|---|
Chromosome Location | chr2:212766614-212773932 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9653337 | chr2:212766614-212766615 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs569451801 | chr2:212766621-212766622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs16847178 | chr2:212766642-212766643 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs183225412 | chr2:212766661-212766662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568539995 | chr2:212766684-212766685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs202143857 | chr2:212766748-212766749 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187915583 | chr2:212766750-212766751 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191216630 | chr2:212766751-212766752 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200580474 | chr2:212766759-212766760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148698110 | chr2:212766772-212766773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563631180 | chr2:212766891-212766892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539351806 | chr2:212766938-212766939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs377222556 | chr2:212766939-212766940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575944189 | chr2:212766942-212766943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs370496702 | chr2:212766967-212766968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183718957 | chr2:212766983-212766984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535962633 | chr2:212767014-212767015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77164643 | chr2:212767063-212767064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72933733 | chr2:212767073-212767074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187850135 | chr2:212767105-212767106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548976944 | chr2:212767121-212767122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563921851 | chr2:212767137-212767138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532990572 | chr2:212767215-212767216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73073348 | chr2:212767230-212767231 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs73073349 | chr2:212767364-212767365 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs374463408 | chr2:212767379-212767380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545965030 | chr2:212767425-212767426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34675688 | chr2:212767449-212767450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556812213 | chr2:212767470-212767471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73073350 | chr2:212767480-212767481 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs568684998 | chr2:212767511-212767512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534018812 | chr2:212767556-212767557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs370098948 | chr2:212767566-212767567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547894917 | chr2:212767628-212767629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs146255295 | chr2:212767669-212767670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73073353 | chr2:212767670-212767671 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs192933221 | chr2:212767701-212767702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569588255 | chr2:212767707-212767708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139315430 | chr2:212767725-212767726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555128777 | chr2:212767728-212767729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75556861 | chr2:212767767-212767768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540766324 | chr2:212767784-212767785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557874648 | chr2:212767795-212767796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143647646 | chr2:212767796-212767797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543359299 | chr2:212767821-212767822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs146823610 | chr2:212767832-212767833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368131500 | chr2:212767844-212767845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532006801 | chr2:212767875-212767876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142169886 | chr2:212767880-212767881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372068690 | chr2:212767881-212767882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212765200-212768800 | Weak transcription | Brain Angular Gyrus | brain |
2 | chr2:212765400-212766800 | Enhancers | Fetal Heart | heart |
3 | chr2:212765600-212771400 | Weak transcription | Brain Substantia Nigra | brain |
4 | chr2:212766400-212766800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr2:212766400-212768000 | Weak transcription | Brain Germinal Matrix | brain |
6 | chr2:212766400-212771600 | Weak transcription | Brain Anterior Caudate | brain |
7 | chr2:212766800-212768800 | Weak transcription | Fetal Heart | heart |
8 | chr2:212768000-212769800 | Enhancers | Brain Germinal Matrix | brain |
9 | chr2:212768600-212769000 | Enhancers | Brain Hippocampus Middle | brain |
10 | chr2:212768800-212769200 | Enhancers | Brain Angular Gyrus | brain |
11 | chr2:212768800-212769200 | Enhancers | Fetal Heart | heart |
12 | chr2:212769200-212769400 | Weak transcription | Brain Angular Gyrus | brain |
13 | chr2:212769200-212772000 | Weak transcription | Fetal Heart | heart |
14 | chr2:212769400-212769800 | Enhancers | Brain Angular Gyrus | brain |
15 | chr2:212771400-212771800 | Enhancers | Brain Substantia Nigra | brain |
16 | chr2:212771600-212771800 | Enhancers | Brain Anterior Caudate | brain |
17 | chr2:212771600-212772200 | Enhancers | Brain Cingulate Gyrus | brain |
18 | chr2:212772000-212772600 | Enhancers | Fetal Heart | heart |
19 | chr2:212772600-212774200 | Weak transcription | Fetal Heart | heart |